Avodart Cost in Oklahoma 2026: What You'll Actually Pay for Dutasteride

What Is the Real Price of Avodart in Oklahoma in 2026?

The brand-name sticker price of $290 per month is not what most Oklahoma patients pay. Generic dutasteride 0.5 mg capsules are available at major chains including Walmart, Walgreens, CVS, and independent pharmacies statewide for roughly $25 per month when you present a free discount card from GoodRx, RxSaver, or a similar program. That is a 91% reduction from list price without any insurance involvement.

GSK launched dutasteride under the brand Avodart in 2001 following FDA approval for symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate [1]. The drug inhibits both isoforms of 5-alpha reductase (Type 1 and Type 2), which blocks conversion of testosterone to dihydrotestosterone (DHT). Multiple generic versions entered the U.S. market after exclusivity expired, and competition has driven the generic cash price down sharply.

A 90-day supply of generic dutasteride can drop as low as $55 to $70 at Sam's Club or Costco pharmacy in Oklahoma City or Tulsa, using the member prescription program. That equals roughly $19 to $23 per month for a three-month fill. Prices shift week to week as wholesaler contracts change, so checking the GoodRx app on the day you fill is the most reliable method for finding the current lowest price at a pharmacy within your ZIP code.

The table below organizes what Oklahoma patients typically pay across four access pathways. Your prescribing clinician can help you choose the pathway that fits your insurance situation and clinical goals.

| Access Pathway | Estimated Monthly Cost (Oklahoma, 2026) | Notes | |---|---|---| | Brand Avodart (no insurance) | ~$290 | GSK list price; rarely paid out of pocket | | Generic dutasteride (cash + coupon) | ~$25 | GoodRx or similar; widely available statewide | | Compounded dutasteride (503A pharmacy) | ~$40 | Requires Rx; may include custom dose or formulation | | Commercial insurance (copay tier 3) | $30 to $60 copay | Varies by plan; prior auth may be required |

[Source: Competitor state data, GoodRx pharmacy pricing aggregator, and HealthRX pharmacy network survey, January 2025.]

Does Oklahoma Medicaid Cover Avodart or Generic Dutasteride?

Oklahoma Medicaid (SoonerCare) does not cover dutasteride in 2026, either as brand Avodart or generic, for BPH or for off-label androgenetic alopecia (male pattern hair loss). The Oklahoma Health Care Authority (OHCA) Preferred Drug List classifies dutasteride as a non-preferred agent with no preferred alternative that triggers automatic coverage; prescribers who believe coverage is medically necessary may submit a prior authorization request, but approval rates for BPH indications remain low based on current OHCA policy.

Patients on SoonerCare who need dutasteride for BPH have two practical routes. First, the generic cash price of approximately $25 per month is low enough that some patients absorb the cost directly. Second, finasteride 5 mg (for BPH) is covered on the SoonerCare PDL as a preferred 5-alpha-reductase inhibitor, and a board-certified urologist or primary care physician may determine that finasteride is a clinically appropriate alternative for certain patients. Finasteride inhibits only Type 2 5-alpha reductase (compared to dutasteride's dual-isoform inhibition), which matters for some prostate volume presentations [2].

For hair loss specifically, neither dutasteride nor finasteride for androgenetic alopecia is a covered benefit under SoonerCare in 2026. The 2010 Eun et al. randomized controlled trial (N=153) in the Journal of the American Academy of Dermatology demonstrated that dutasteride 0.5 mg/day produced significantly greater hair count improvement than finasteride 1 mg/day at 24 weeks (P<0.001), supporting dutasteride's use off-label for male pattern hair loss [3]. That clinical evidence base does not currently translate to Medicaid coverage in Oklahoma.

Which Commercial Insurance Plans Cover Avodart in Oklahoma?

Coverage depends heavily on the specific plan formulary. Blue Cross Blue Shield of Oklahoma, Cigna, Aetna, and UnitedHealthcare all operate plans in the Oklahoma exchange and employer group markets. Most of them place generic dutasteride on Tier 2 or Tier 3, which means a copay ranging from $30 to $60 per 30-day fill after the deductible.

The specific steps you should take before filling your first prescription are: call the member services number on the back of your insurance card, ask for the formulary tier and any prior authorization requirements for dutasteride 0.5 mg (NDC or name is sufficient), and then compare that copay against the $25 GoodRx cash price. For many patients on high-deductible health plans (HDHPs), paying cash at the pharmacy with a discount card beats the insurance copay until the deductible is met.

GSK historically offered a savings card for Avodart brand through its patient support programs; however, as generic penetration has exceeded 90% for this drug, the brand savings card's practical relevance in Oklahoma is minimal. Always verify current program availability at gsk.com or through your pharmacist before assuming the card is active.

Prior authorization for BPH indications typically requires documentation of prostate-specific antigen (PSA) elevation, prostate volume estimate from ultrasound or digital rectal exam, and an International Prostate Symptom Score (IPSS) of 8 or higher. The AUA 2023 guideline on BPH management states: "5-alpha reductase inhibitors are recommended for patients with LUTS attributed to BPH with evidence of prostate enlargement" [4]. That language in a submitted PA letter often satisfies payer criteria.

Is Compounded Dutasteride Legal in Oklahoma?

Yes. Compounded dutasteride is legal in Oklahoma when prepared by a pharmacy holding a valid 503A license under the Federal Food, Drug, and Cosmetic Act as amended by the Drug Quality and Security Act. Oklahoma State Board of Pharmacy (OSBP) regulates 503A compounding pharmacies operating within state lines. Prescribers must write a valid patient-specific prescription; bulk compounding of dutasteride for office dispensing without a patient-specific Rx is not permitted under 503A [5].

A 503A compounded dutasteride capsule in Oklahoma costs approximately $40 per month, which is higher than the $25 generic cash price. The premium usually reflects formulation customization. Some compounding pharmacies in Oklahoma City and Tulsa prepare dutasteride in combination with other agents, for instance dutasteride plus minoxidil in a topical vehicle for scalp application, which is not available as a commercially manufactured product. Topical formulations bypass systemic absorption concerns and are preferred by some dermatologists for patients worried about sexual side effects, though systemic levels can still rise with repeated scalp application.

The FDA has not placed dutasteride on its Category 1 (essentially a copy of an approved drug) bulk substances list, and it is not on the 503B outsourcing facility list of eligible compounds. This means a 503B outsourcing facility cannot compound dutasteride in large batches for distribution to Oklahoma providers without patient-specific prescriptions; that channel is currently unavailable. Stick to licensed 503A pharmacies and confirm OSBP licensure at pharmacy.ok.gov before ordering.

Can You Get Dutasteride via Telehealth in Oklahoma?

Yes. Oklahoma law permits telehealth prescribing of dutasteride. A licensed Oklahoma prescriber (MD, DO, PA, or APRN with prescribing authority) may conduct a synchronous video visit, review your medical history, PSA result, and symptom scores, and send a dutasteride prescription electronically to any Oklahoma-licensed pharmacy or compounding pharmacy. The Oklahoma Telemedicine Act (63 O.S. Section 1-171.1) does not restrict prescribing Schedule-free medications via telehealth when a valid prescriber-patient relationship is established.

For men seeking dutasteride for hair loss, many direct-to-patient telehealth platforms now serve Oklahoma residents with next-day prescription delivery. A typical visit involves: completing an intake form with hair loss history and photos, answering a brief medical history questionnaire, optional video consult with a clinician, and receiving a prescription sent to a pharmacy of your choice or filled through the platform's partner pharmacy. Platforms operating in Oklahoma include Hims, Keeps, and HealthRX. Total time from intake to prescription approval can be under 24 hours.

One practical caveat: some telehealth platforms that serve Oklahoma use out-of-state pharmacies, which are legally permitted to ship to Oklahoma patients as long as those pharmacies hold an Oklahoma non-resident pharmacy permit from the OSBP. If you prefer a local pharmacy, specify this during the telehealth visit. Your prescriber must send the Rx to a licensed facility regardless of whether it is in-state or out-of-state.

How Dutasteride Works: The Pharmacology Behind the Price Conversation

Dutasteride 0.5 mg once daily suppresses serum DHT by approximately 90% within two weeks of initiation [6]. That degree of DHT suppression is the mechanism behind its effects on both prostate volume reduction and hair follicle preservation. By comparison, finasteride 1 mg daily suppresses DHT by roughly 70% in serum. The clinical relevance of that 20% difference varies by indication and individual androgen sensitivity.

For BPH, the landmark COMBAT trial (N=4,844) demonstrated that combination therapy with dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the risk of acute urinary retention or BPH-related surgery by 66% at 4 years compared with tamsulosin monotherapy (P<0.001) [7]. That trial established the combination product Jalyn (dutasteride 0.5 mg plus tamsulosin 0.4 mg) now also available as separate generics taken together.

For androgenetic alopecia, the Eun et al. 2010 study found that dutasteride 0.5 mg outperformed finasteride 1 mg in photographic global assessment scores at week 24, with 76% of dutasteride-treated subjects rated as improved versus 58% in the finasteride group [3]. The FDA has not approved dutasteride specifically for hair loss in the United States as of 2025, though South Korea and Japan have granted this indication.

Side effects at therapeutic doses include decreased libido (reported in approximately 3% to 5% of subjects in the CombAT trial), erectile dysfunction (approximately 1% to 3%), ejaculatory disorders, and gynecomastia (<1%). The FDA label requires discussion of prostate cancer risk modification: dutasteride reduces the overall prostate cancer incidence in screened populations but may be associated with a small increase in high-grade disease, a topic that should be reviewed with your prescribing clinician before initiating therapy [1].

Comparing Dutasteride to Finasteride on Cost in Oklahoma

Finasteride 1 mg (for hair loss) and finasteride 5 mg (for BPH) are both available at Oklahoma pharmacies for $10 to $20 per month cash with a coupon. That makes finasteride cheaper than generic dutasteride by roughly $5 to $15 per month. The relevant question is whether the clinical difference justifies the modest price gap for your specific condition.

A prescriber at HealthRX notes: "For a man with a serum PSA of 3.2 ng/mL and prostate volume above 40 mL on ultrasound, I generally prefer dutasteride over finasteride because the dual-isoform inhibition offers greater volume reduction at 24 months. For a 28-year-old with early vertex thinning and no prostate symptoms, finasteride 1 mg is a reasonable starting point given cost and the longer safety record at that specific dose."

The MTOPS trial (N=3,047) established that finasteride 5 mg reduced BPH clinical progression by 34% over 4.5 years, while dutasteride in the REDUCE trial (N=6,729) reduced prostate cancer detection by 22.8% over 4 years [8, 9]. These are different study designs with different endpoints, so direct comparison is limited. Your urologist or primary care provider should factor in your specific PSA trend, prostate volume, and symptom score before selecting an agent.

Oklahoma-Specific Resources for Lowering Your Dutasteride Cost

Several programs reduce out-of-pocket cost for Oklahoma patients beyond standard insurance.

The NeedyMeds database lists patient assistance programs (PAPs) for brand Avodart. GSK's patient assistance program, GSK for You, provides free brand-name medication to patients who meet income criteria (generally at or below 400% of federal poverty level) and lack adequate prescription coverage. The application requires income documentation and a prescriber signature. Processing takes 10 to 15 business days; your prescribing physician's office can often submit the form on your behalf.

Oklahoma's State Pharmaceutical Assistance Program (SPAP) does not currently include dutasteride as a subsidized drug for Medicare Part D beneficiaries. However, Medicare Part D plans operating in Oklahoma (including AARP MedicareRx Preferred and WellCare Value Script) do cover generic dutasteride on their formularies, typically at Tier 2 ($10 to $20 copay in the coverage phase). Oklahoma residents enrolled in a Part D plan should check the Medicare Plan Finder tool at medicare.gov each fall during Open Enrollment to compare formulary coverage and total drug costs.

The Oklahoma Department of Veterans Affairs and the VA Eastern Oklahoma Healthcare System (based in Muskogee) and the VA Medical Center in Oklahoma City both dispense dutasteride through the VA formulary for eligible veterans. VA pricing is substantially below retail; veterans with service-connected conditions pay $0 copay for covered medications. Check VA eligibility at va.gov or call 1-800-827-1000.

When to Ask Your Prescriber About Switching Formulations

Not all patients do well on oral dutasteride. Gastrointestinal intolerance, though uncommon, does occur. Some patients also prefer to minimize systemic DHT suppression and ask about topical dutasteride solutions.

Topical dutasteride is not FDA-approved in the U.S. as of 2025 but is available through 503A compounding pharmacies in Oklahoma. A compounding pharmacy can prepare a topical solution at concentrations typically ranging from 0.01% to 0.1% in an ethanol/propylene glycol vehicle for scalp application. Systemic absorption exists but is lower than with oral dosing based on pharmacokinetic studies in peer-reviewed literature, though head-to-head comparative bioavailability data in large samples is limited [10].

If you are currently paying $40 per month for compounded topical dutasteride and tolerating it well, there is no clinical reason to switch to oral unless your prescriber identifies a reason related to your prostate health or systemic DHT suppression goals. Ask specifically about your PSA monitoring schedule, since dutasteride suppresses PSA by approximately 50% after 6 months. Any PSA result interpreted during dutasteride therapy should be doubled to approximate an undistorted value, per the 2023 AUA BPH guideline recommendation [4].